22 February 2021

Apomorphine therapy: managing safety and tolerability

Clinical Parkinson’s SPONSORED

Sponsored

Parkinson’s Disease Nurse, David Tsui discusses the safety and tolerability of apomorphine and strategies for managing adverse effects.

To read the rest of this article you need to be a Medical Republic Member and registered with AHPRA, Please login below if you have an account or sign up to join.

Join Now / Login